May 22, 2017 09:56 AM EDT
News Briefing

Abl­ynx grabs a €15M mile­stones pay­ment from Mer­ck KGaA; Eye­Gate surges on Valeant pay­out

John Carroll

Editor & Founder

→ Bel­gium’s Abl­ynx has teed up one of its Nanobod­ies for os­teoarthri­tis for Mer­ck KGaA. The Ger­man com­pa­ny ac­cept­ed it and will now take …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

No­vo Nordisk is feel­ing the com­pe­ti­tion from com­pound­ed GLP-1s, ex­ec says

Bris­tol My­ers, Ky­owa Kirin dis­close lay­offs

Am­gen an­nounces hold on Phase 1 obe­si­ty can­di­date, pipeline cuts

Eye­Point shares more mid-stage da­ta for ther­a­py try­ing to com­pete with Re­gen­eron's Eylea

Pfiz­er says it has at least $10B avail­able for deals in 2025, with a fo­cus on pipeline

Up­dat­ed: RFK Jr. ad­vances out of Sen­ate com­mit­tee with Cas­sidy’s sup­port

A service from the Financial Times